The COVID-19 response in Kentucky involves stakeholders at every level of the healthcare system. The following documents and links reflect the most current guidance for healthcare providers, laboratories and local public health.
Lab Services Form To be completed by labs offering COVID-19 services.
SAMHSA OTP Guidance: SAMHSA issued guidance allowing states with and without emergency declarations to allow Opioid Treatment Programs (OTPs) to provide 28 days of take-home medication to stable patients and 15 days of medication to less stable patients whom the OTP believes can responsibly manage this amount of medication.
SAMHSA 42 CFR Part 2 Guidance: SAMHSA issued guidance which allows providers to share patient SUD diagnosis information that would normally be protected under 42 CFR Part 2 in instances of a bona fide medical emergency. Usage of the medical emergency exception must be documented by providers.
CMS Guidance to Catastrophic Coverage Plans: CMS issued an FAQ clarifying that catastrophic coverage plans must include coverage of COVID-19 diagnosis and treatment under the Essential Health Benefits. CMS will waive enforcement actions against any such plan which provides COVID-19 services before patients pay the plan’s deductible, and encourages plans and states to provide such pre-deductible coverage.